532039 ZENOTECH

Zenotech Laboratories Share Price

₹71.20 +0.11 (0.15%)

23 Dec, 2024 04:12

SIP TrendupStart SIP in ZENOTECH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -6.56%
  • Over 3 Month -23.69%
  • Over 6 Month + 17.01%
  • Over 1 Year + 7.88%
SIP Lightning

Smart Investing Starts Here Start SIP with Zenotech Laboratories for Steady Growth!

Invest Now

Zenotech Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Zenotech Laboratories Financials

Zenotech Laboratories Technicals

EMA & SMA

Current Price
₹71.20
+ 0.11 (0.15%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹74.42
  • 50 Day
  • ₹77.60
  • 100 Day
  • ₹77.16
  • 200 Day
  • ₹73.71

Resistance and Support

70.7 Pivot Speed
  • R3 76.40
  • R2 74.70
  • R1 72.40
  • S1 68.40
  • S2 66.70
  • S3 64.40

What's your outlook on Zenotech Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Zenotech Laboratories has an operating revenue of Rs. 37.69 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 27% is great, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Zenotech Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Quarterly Results
2024-07-26 Quarterly Results
2024-05-01 Audited Results
2024-01-29 Quarterly Results
2023-10-30 Quarterly Results

Zenotech Laboratories F&O

Zenotech Laboratories Shareholding Pattern

68.84%
0.01%
22.66%
8.49%

About Zenotech Laboratories

  • NSE Symbol
  • ZENOTECH
  • BSE Symbol
  • 532039
  • ISIN
  • INE486F01012

Similar Stocks to Zenotech Laboratories

Zenotech Laboratories FAQs

Zenotech Laboratories share price is ₹71 As on 23 December, 2024 | 03:58

The Market Cap of Zenotech Laboratories is ₹434.5 Cr As on 23 December, 2024 | 03:58

The P/E ratio of Zenotech Laboratories is 65.1 As on 23 December, 2024 | 03:58

The PB ratio of Zenotech Laboratories is 4.8 As on 23 December, 2024 | 03:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23